SERPINA1 and COVID-19: Because NE activity quickly dissipates, due to the high levels of the A1AT protease inhibitor that binds to NE and blocks its activity [39], we considered the appealing alternative to measure concentrations of NE-A1AT complexes in plasma from sixty-nine COVID-19 patients and twenty-five non-COVID-19 controls.